Groundbreaking AI-based cancer treatment developed by Israeli researchers - HEALTH & SCIENCE - Jerusalem Post

The original scan (left) and the areas where information was extracted (in red and green, right) using the technology developed at the Technion. Researchers at Technion-Israel Institute of Technology have developed a deep learning-based method for mapping critical receptors on cancer cells, which is expected to significantly improve personalized cancer treatment, the Office of the Technion Spokesperson reported on Wednesday. According to the report, the new technology extracts molecular information from images of breast cancer biopsies that underwent hematoxylin and eosin (H&E) staining. The staining, made by a common dye used to test biopsy tissue, allows the pathologist to identify the type of cancer and its severity but does not allow the identification of biological characteristics that are crucial for personalized treatment.